
Adipogen/(S)-CR8/AG-MR-C0004-M050/50 mg
商品编号:
AG-MR-C0004-M050
品牌:
Adipogen Inc
市场价:
¥12000.00
美元价:
7200.00
产品分类:
其他试剂
公司分类:
Other_reagents
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
ProductDetails | |
---|---|
Synonyms | 2-(S)-(1-Ethyl-2-hydroxyethylamino)-6-(4-(2-pyridyl)benzyl)-9-isopropylpurine |
ProductType | Chemical |
Properties | |
Formula | C24H29N7O |
MW | 431.5 |
CAS | 1084893-56-0 |
PurityChemicals | ≥99%(NMR) |
Appearance | Whitetooff-whitesolid. |
Solubility | SolubleinDMSOorethanol. |
Reconstitution | Stocksolutionscanbemadeupto10mMinDMSO. |
Identity | Determinedby1H-NMR. |
InChiKey | HOCBJBNQIQQQGT-IBGZPJMESA-N |
ShippingandHandling | |
Shipping | AMBIENT |
ShortTermStorage | +4°C |
LongTermStorage | -20°C |
HandlingAdvice | Keepunderinertgas. Protectfromlight. |
Use/StABIlity | Stableforatleast2yearsafterreceiptwhenstoredat-20°C. |
Documents | |
MSDS | ![]() |
ProductSpecificationSheet | |
Datasheet | ![]() |
- Potentcyclin-dependentkinase(CDK)1,2,5,and9inhibitor[1,2].
- Apoptosisinducer[1,3,5].
- Inhibitstheproliferationofvariouscancercelllines[1].
- Inhibitscystsformationinculture[4].
- Caseinkinase1(CK1δ/ε)andDyrk1Ainhibitor[1].
- DownregulatesexpressionofMcl-1andMYCN.
- Neuroprotectiveinexperimentaltraumaticbraininjury.
- Potentialanti-inflammatorycompound.
- Potentialantidiabeticcompound.
ProductReferences
- CR8,apotentandselective,roscovitine-derivedinhibitorofcyclin-dependentkinases:K.Bettayeb,etal.;Oncogene27,5797(2008)
- Roscovitine-derived,dual-specificityinhibitorsofcyclin-dependentkinasesandcaseinkinases1:N.Oumata,etal.;J.Med.Chem.51,5229(2008)
- CDKinhibitorsroscovitineandCR8triggerMcl-1down-regulationandapoptoticcelldeathinneuroblastomacells:K.Bettayeb,etal.;GenesCancer1,369(2010)
- CDKinhibitorsR-roscovitineandS-CR8effectivelyblockrenalandhepaticcystogenesisinanorthologousmodelofADPKD:N.O.Bukanov,etal.;CellCycle11,4040(2012)
- CR8,aselectiveandpotentCDKinhibitor,providesneuroprotectioninexperimentaltraumaticbraininjury.S.V.KabADI,etal.;Neurotherapeutics9,405(2012)
- InhibitionofNF-κB-mediatedsignalingbythecyclin-dependentkinaseinhibitorCR8overcomesprosurvivalstimulitoinduceapoptosisinchroniclymphocyticleukemiacells:E.Cosimo,etal.;Clin.CancerRes.19,2393(2013)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。
联络我们